Efficacy and Safety of Infliximab Biosimilar in Treatment of Resistant Hidradenitis Suppurativa

Condition:   Hidradenitis Suppurativa Intervention:   Biological: Infliximab biosimilar Sponsor:   Services Institute of Medical Sciences, Pakistan Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials